1
|
Waechtler A, Cezanne B, Maillard D, Sun R, Wang S, Wang J, Harder A. Praziquantel - 50 Years of Research. ChemMedChem 2023; 18:e202300154. [PMID: 37009677 DOI: 10.1002/cmdc.202300154] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2023] [Revised: 03/31/2023] [Accepted: 03/31/2023] [Indexed: 04/04/2023]
Abstract
Investigations on praziquantel (PZQ) started fifty years ago by a cooperation between Bayer AG and Merck KGaA. Until today PZQ is the drug of choice for schistosomiasis in human medicine and used in many combinations with antinematode drugs in veterinary medicine. The Sm.TRPMPZQ , a Ca2+ -permeable transient receptor potential (TRP) channel, has been discovered as primary target of PZQ during the last decade. Furthermore, there is a short overview of routes of large-scale synthesis of racemic and pure (R)-PZQ. Until now racemic PZQ is used in veterinary and human medicine. In 2012 the Pediatric Praziquantel Consortium started PZQ chemistry and process development of pure (R)-PZQ for human application. It is hoped that (R)-PZQ will become available for pediatric use soon. The knowledge of the binding pocket of PZQ in Sm.TRPMPZQ allows to design synthesis of PZQ-derivatives of the next generation for a target-site directed screening. A similar screening should also be started for Fasciola hepatica TRPMPZQ .
Collapse
Affiliation(s)
- Andreas Waechtler
- Central Process Development Department (EL-OTS) Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany
| | - Bertram Cezanne
- Central Process Development Department (EL-OTS) Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany
| | - David Maillard
- Central Process Development Department (EL-OTS) Merck KGaA, Frankfurter Str. 250, 64293, Darmstadt, Germany
| | - Rui Sun
- R&D Department, Valiant Pharmaceutical Co. Ltd., Taiyuan Road No. 60, YEDA, Yantai, Shandong, 264006, China
| | - Shaofang Wang
- Technical Department, Valiant Corporation Ltd., Wuzhishan Road No. 11, YEDA, Yantai, Shandong, 264006, China
| | - Jihua Wang
- Technical Department, Valiant Corporation Ltd., Wuzhishan Road No. 11, YEDA, Yantai, Shandong, 264006, China
| | - Achim Harder
- Department WE Biology, Institute of Biology, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225, Düsseldorf, Germany
| |
Collapse
|
2
|
Bityukov OV, Vil' VA, Nikishin GI, Terent'ev AO. Alkene, Bromide, and ROH – How To Achieve Selectivity? Electrochemical Synthesis of Bromohydrins and Their Ethers. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202100161] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Oleg V. Bityukov
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, 47 Leninsky prosp. 119991 Moscow Russian Federation
- All-Russian Research Institute for Phytopathology B. Vyazyomy Moscow Region 143050 Russian Federation
| | - Vera A. Vil'
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, 47 Leninsky prosp. 119991 Moscow Russian Federation
- All-Russian Research Institute for Phytopathology B. Vyazyomy Moscow Region 143050 Russian Federation
| | - Gennady I. Nikishin
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, 47 Leninsky prosp. 119991 Moscow Russian Federation
| | - Alexander O. Terent'ev
- N. D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences, 47 Leninsky prosp. 119991 Moscow Russian Federation
- All-Russian Research Institute for Phytopathology B. Vyazyomy Moscow Region 143050 Russian Federation
| |
Collapse
|
3
|
Gómez ME, Gentile EA, Martini MF, Cuestas ML, Mathet VL, Moltrasio GY, Moglioni AG. Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon. Molecules 2019; 24:molecules24050990. [PMID: 30862130 PMCID: PMC6429379 DOI: 10.3390/molecules24050990] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2019] [Revised: 02/28/2019] [Accepted: 03/02/2019] [Indexed: 11/16/2022] Open
Abstract
Here, we report a convenient synthetic procedure for the preparation of four novel indanyl carbanucleoside derivatives in the racemic form. The action of these compounds against hepatitis C virus was evaluated in vitro using the replicon cell line, Huh7.5 SG. Contrary to our expectations, all these compounds did not inhibit, but rather promoted HCV genotype 1b (HCVg1b) replication. Similar effects have been reported for morphine in the replicon cell lines, Huh7 and Huh8. Several biological experiments and computational studies were performed to elucidate the effect of these compounds on HCVg1b replication. Based on all the experiments performed, we propose that the increase in HCVg1b replication could be mediated, at least in part, by a similar mechanism to that of morphine on the enhancement of this replication. The presence of opioid receptors in Huh7.5 SG cells was indirectly determined for the first time in this work.
Collapse
Affiliation(s)
- Matías E Gómez
- Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1113AAD, Argentina.
| | - Emiliano A Gentile
- Instituto de Investigaciones en Microbiología y Parasitología Médica, CONICET-Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1121ABF, Argentina.
| | - M Florencia Martini
- Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1113AAD, Argentina.
- Instituto de la Química y Metabolismo del Fármaco, CONICET-Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1113AAD, Argentina.
| | - María L Cuestas
- Instituto de Investigaciones en Microbiología y Parasitología Médica, CONICET-Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1121ABF, Argentina.
| | - Verónica L Mathet
- Instituto de Investigaciones en Microbiología y Parasitología Médica, CONICET-Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1121ABF, Argentina.
| | - Graciela Y Moltrasio
- Cátedra de Química Orgánica II, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1113AAD, Argentina.
| | - Albertina G Moglioni
- Cátedra de Química Medicinal, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1113AAD, Argentina.
- Instituto de la Química y Metabolismo del Fármaco, CONICET-Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires C1113AAD, Argentina.
| |
Collapse
|
4
|
β-Carbon activation of saturated carboxylic esters through N-heterocyclic carbene organocatalysis. Nat Chem 2013; 5:835-9. [DOI: 10.1038/nchem.1710] [Citation(s) in RCA: 226] [Impact Index Per Article: 20.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2013] [Accepted: 06/14/2013] [Indexed: 11/09/2022]
|
5
|
Rouf A, Gupta P, Aga MA, Kumar B, Parshad R, Taneja SC. Cyclic trans-β-amino alcohols: preparation and enzymatic kinetic resolution. ACTA ACUST UNITED AC 2011. [DOI: 10.1016/j.tetasy.2011.11.019] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
6
|
Woelfle M, Seerden JP, de Gooijer J, Pouwer K, Olliaro P, Todd MH. Resolution of praziquantel. PLoS Negl Trop Dis 2011; 5:e1260. [PMID: 21949890 PMCID: PMC3176743 DOI: 10.1371/journal.pntd.0001260] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2011] [Accepted: 06/15/2011] [Indexed: 11/22/2022] Open
Abstract
Background Praziquantel remains the drug of choice for the worldwide treatment and control of schistosomiasis. The drug is synthesized and administered as a racemate. Use of the pure active enantiomer would be desirable since the inactive enantiomer is associated with side effects and is responsible for the extremely bitter taste of the pill. Methodology/Principal Findings We have identified two resolution approaches toward the production of praziquantel as a single enantiomer. One approach starts with commercially available praziquantel and involves a hydrolysis to an intermediate amine, which is resolved with a derivative of tartaric acid. This method was discovered through an open collaboration on the internet. The second method, identified by a contract research organisation, employs a different intermediate that may be resolved with tartaric acid itself. Conclusions/Significance Both resolution procedures identified show promise for the large-scale, economically viable production of praziquantel as a single enantiomer for a low price. Additionally, they may be employed by laboratories for the production of smaller amounts of enantiopure drug for research purposes that should be useful in, for example, elucidation of the drug's mechanism of action. The drug praziquantel (PZQ) is used very widely in both animal and human medicine, where it is the mainstay of the treatment of the neglected tropical disease schistosomiasis. The drug is currently manufactured and administered as a racemate (1∶1 mixture of enantiomers) but for various reasons the large-scale production of PZQ as the single active enantiomer is very desirable. We describe here the preparation of praziquantel as a single enantiomer using classical resolution. The protocols are experimentally simple and inexpensive. One method was found and validated by an unusual research mechanism—open science—where the details of the collaboration (involving academic and industrial partners) and all research data were available on the web as they were acquired, and anyone could participate. The other route was found in parallel by a contract research organisation. Besides being possible routes by which praziquantel may be produced in large quantities for the affected communities, it is also hoped that these methods can be used for the production of smaller quantities of enantiopure PZQ for pharmacological studies.
Collapse
Affiliation(s)
- Michael Woelfle
- School of Chemistry, The University of Sydney, Sydney, New South Wales, Australia
| | | | | | | | - Piero Olliaro
- UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland
| | - Matthew H. Todd
- School of Chemistry, The University of Sydney, Sydney, New South Wales, Australia
- * E-mail:
| |
Collapse
|
7
|
Hansen MM, Borders SSK, Clayton MT, Heath PC, Kolis SP, Larsen SD, Linder RJ, Reutzel-Edens SM, Smith JC, Tameze SL, Ward JA, Weigel LO. Development of a Practical Synthesis of an Aminoindanol-Derived M1 Agonist. Org Process Res Dev 2009. [DOI: 10.1021/op800243q] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Marvin M. Hansen
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Sandra S. K. Borders
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Marcella T. Clayton
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Perry C. Heath
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Stanley P. Kolis
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Samuel D. Larsen
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Ryan J. Linder
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Susan M. Reutzel-Edens
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Justin C. Smith
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Shella L. Tameze
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Jeffrey A. Ward
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| | - Leland O. Weigel
- Eli Lilly and Company, Chemical Product Research and Development Division and Pharmaceutical Sciences Research and Development Division, Indianapolis, Indiana 46285, U.S.A
| |
Collapse
|
8
|
Synoradzki L, Bernaś U, Ruśkowski P. TARTARIC ACID AND ITSO-ACYL DERIVATIVES. PART 2. APPLICATION OF TARTARIC ACID AND OFO-ACYL TARTARIC ACIDS AND ANHYDRIDES. RESOLUTION OF RACEMATES. ORG PREP PROCED INT 2008. [DOI: 10.1080/00304940809458084] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Osorio-Lozada A, Olivo HF. Indene-based thiazolidinethione chiral auxiliary for propionate and acetate aldol additions. Org Lett 2008; 10:617-20. [PMID: 18205374 DOI: 10.1021/ol702980p] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
An indene-based thiazolidinethione chiral auxiliary was prepared in two steps from trans-1-amino-2-indanol. Chlorotitanium enolates of this chiral auxiliary delivered excellent diastereoselectivities in propionate and acetate aldol additions. The chiral auxiliary was easily removed to deliver several valuable functionalities.
Collapse
Affiliation(s)
- Antonio Osorio-Lozada
- Division of Medicinal and Natural Products Chemistry, The University of Iowa, Iowa City, Iowa 52242, USA
| | | |
Collapse
|
10
|
Waykole LM, McKenna JJ, Bach A, Prashad M, Repič O, Blacklock TJ. Amino Acids as a Chiral Pool: Synthesis of (S)‐and (R)‐2‐N‐Carbomethoxy‐5‐aminoindane from (S)‐ and (R)‐Phenylalanines. SYNTHETIC COMMUN 2007. [DOI: 10.1080/00397910701226905] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|